KBW Lifts TMP Target as Stock Outpaces Regional Peers

Tompkins Financial reports Q2 results on July 29 after a run that has left it trading above its own analyst consensus — a tension the print will have to resolve.

The clearest pre-earnings signal is in analyst coverage. Keefe, Bruyette & Woods raised its price target to $105 yesterday while maintaining an Outperform rating, the most recent action in a coverage base split between conviction and caution. Piper Sandler, the only other active voice, holds a Neutral with a $87 target — well below where the stock trades at $99.68. That gap between the two firms defines the bull-bear divide: KBW sees further upside from a regional bank delivering on earnings momentum; Piper's more cautious stance implies the recent rally has run ahead of fundamentals, with the mean consensus target of $96 sitting roughly 4% below the current price.

The stock's momentum into the print is hard to ignore. TMP is up nearly 7% on the week and 6% over the past month, a move that has outpaced most of its correlated peers heading into earnings day. FISI and AMTB both rose sharply on the session, with AMTB up over 10% — a broader regional bank tailwind that may be lifting TMP along with the group. The single-session dip of 1.4% on Monday looks like consolidation rather than distribution.

Short interest and borrow conditions offer no meaningful counter-narrative here. At just under 2% of the free float, short positioning is low and has eased roughly 8.5% over the past week. Borrow availability is extraordinarily loose — more than 5,000% of shares short are available to lend, and cost to borrow is a negligible 0.45%, down sharply over recent weeks. There is simply no short-side pressure in this stock ahead of the print. The ORTEX short score of 34, in the lower-middle of its recent range, confirms the picture: this is not a name where bears are making a concentrated bet.

The July 29 print will test whether Tompkins can deliver results that justify a stock price trading above even the more bullish of its two analyst targets.